Umoja Biopharma Funding & Investors
Seattle, WA
Umoja Biopharma is a biopharmaceutical company developing next-generation immunotherapies intended to combat cancer. The company's treatment approach retools a patient’s immune system in vivo to direct potent anti-cancer immune cells to a patient’s tumor, augmenting the body’s natural mechanisms for fighting cancer.
umoja-biopharma.comTotal Amount Raised: $363,000,000
Umoja Biopharma Funding Rounds
Series C
$100,000,000
Series C Investors
DCVC BioDouble Point VenturesCormorant Asset ManagementMPM CapitalQiming Venture Partners USACaaS Capital ManagementRTW InvestmentsMyeloma Investment FundAlexandria Venture InvestmentsK2 HealthVenturesARK InvestUniversity of Minnesota FoundationSVFEmerson CollectiveSeries B
$210,000,000
Series B Investors
Cormorant Asset ManagementSVFCaaS Capital ManagementTemasekPresight CapitalRTW InvestmentsSVB LeerinkSeries A
$53,000,000
Series A Investors
MPM CapitalQiming Venture Partners USADCVC Bio
Funding info provided by Diffbot.